Nepal | July 11, 2020

UN virus therapy trial pauses hydroxychloroquine testing

Associated Press
Share Now:

GENEVA: The World Health Organization said Monday that it will temporarily drop hydroxychloroquine — the anti-malarial drug US President Trump says he is taking — from its global study into experimental COVID-19 treatments, saying that its experts need to review all available evidence to date.

In a press briefing, WHO director-general Tedros Adhanom Ghebreyesus said that in light of a paper published last week in the Lancet that showed people taking hydroxychloroquine were at higher risk of death and heart problems, there would be “a temporary pause” on the hydroxychloroquine arm of its global clinical trial.

“This concern relates to the use of hydroxychloroquine and chloroquine in COVID-19,” Tedros said, adding that the drugs are approved treatments for people with malaria or autoimmune diseases. Other treatments in the trial, including the experimental drug remdesivir and an HIV combination therapy, are still being tested.

Tedros said the executive group behind WHO’s global “Solidarity” trial met on Saturday and decided to conduct a comprehensive review of all available data on hydroxychloroquine and that its use in the trial would be suspended for now.

Dr. Michael Ryan, WHO’s emergencies chief, said there was no indication of any safety problems with hydroxychloroquine in the WHO trial to date, but that statisticians would now analyze the information.

“We’re just acting on an abundance of caution based on the recent results of all the studies to to ensure that we can continue safely with that arm of the trial,” he said. WHO said it expected to have more details within the next two weeks.

Last week, Trump announced he was taking hydroxychloroquine although he has not tested positive for COVID-19. His own administration has warned the drug can have deadly side effects, and both the European Medicines Agency and the U.S. Food and Drug Administration warned health professionals last month that the drug should not be used to treat COVID-19 outside of hospital or research settings due to numerous serious side effects that in some cases can be fatal.

Hydroxychloroquine and chloroquine are approved for treating lupus and rheumatoid arthritis and for preventing and treating malaria, but no large rigorous tests have found them safe or effective for preventing or treating COVID-19.


Follow The Himalayan Times on Twitter and Facebook

Recommended Stories:

More from The Himalayan Times:

Infection rate high among returnee migrants

RAJBIRAJ, JULY 9 High rate of COVID-19 infection has been seen among people returning from third countries at present, while the infection rate was high among returnees from India two months ago in Saptari. According to District Public Health Office, of the 154 COVID infected persons being tre Read More...

Nepal at high risk of yet another locust invasion, five large swarms expected to fly in

KATHMANDU: Nepal could possibly be swarmed by locusts yet again as a large swarm is seen moving northward from Rajasthan of India, warned Plant Quarantine and Pesticide Management Centre. Five swarms of locusts are currently spaced out at 400 hectors of the area around Sikar of Rajasthan of India Read More...

Landslide causes major damage

KATHMANDU, JULY 9 The floods and landslides have caused great damage to the 102-megawatt Middle-Bhotekoshi Hydropower Project under construction in Sindhupalchowk district. The floods and landslides in the area, including Jambu Bazaar of Barhabise Municipality, have damaged the Middle-Bhotekos Read More...

735 stranded Nepalis rescued via five flights

KATHMANDU, JULY 9 The government today repatriated 735 stranded people from different countries through five different chartered flights. As per the statistics provided by the Civil Aviation Authority of Nepal (CAAN) office at the Tribhuvan International Airport (TIA), these people were evacua Read More...

Three of a family killed in Lamjung landslide

LAMJUNG: Three members of a family were killed as landslide debris buried a house in Besisahar Municipality-7 of Lamjung district at midnight on Thursday. District Police Office (DPO), Lamjung identified the deceased as Deepak Tamang (30), his wife Bimaya Tamang (26) and their daughter Chhewang T Read More...

In Pictures: Health workers at the frontline

  A health worker collects throat swabs for Polymerase Chain Reaction (PCR) testing of patients at Teku-based Sukraraj Tropical and Infectious Disease Hospital, in Kathmandu, on Thursday, July 9, 2020. Read More...

Japan braces for more heavy rain as death toll rises to 66

TOKYO: Parts of Japan still searching for missing people and evacuating those stranded by deadly floods and mudslides were bracing for more pounding rains through the weekend. The death toll has risen to 66 as of Friday morning, with 16 others still missing, the Fire and Disaster Management Agenc Read More...

Seven killed in landslides at various places in Pokhara

POKHARA: Seven persons were killed in landslides triggered by incessant rain at three places in Pokhara Metropolitan City of Kaski district today. Five persons were killed in Sarangkot, Pokhara-18, and one each at two other places. Landslide debris buried the house belonging to Tanka Bahad Read More...